Aqua Pharma
in press and stories
TRIALS OF PIONEERING NEW ANTI-SEA LICE TREATMENT CONCEPT CARRIED OUT IN SHETLAND
October 2022
A new anti-sea lice treatment concept under development to help make aquaculture more sustainable has successfully completed environmental safety trials of the state-of-the-art equipment in Scotland.
The multinational consortium behind the EITFood funded initiative BREEZE carried out the week-long trials at a salmon farm in Shetland, owned and operated by Scottish Sea Farms. The trials validated modelling already carried out and have shown that the sonic technology to treat fish against sea lice can operate safely in an open marine environment.
SEATRU™ KICKS OFF WITH 2-YEAR RESEARCH PROGRAM
June 2022
Aqua Pharma are joining forces with microbial fingerprinting experts KYTOS to develop SEATRU™ – a unique new service platform offering shrimp farmers worldwide effective microbial control through precise dosing recommendations.
The initiative kicks off in July 2022 with a two-year research project based in Indonesia with local partner eFishery, the world’s largest aquaculture tech start-up.
Aqua pharma expands: opens new office in chile and new subsidiary for salmon farming
May 2022
Chile: The Norwegian supplier of hydrogen peroxide will be based in Puerto Montt for aquaculture and from this year, they will also offer food safety services to the national industry.
The Norwegian provider of disease prevention and control systems for salmon farming, Aqua Pharma, is completing a major expansion in Chile. Recently, it opened new offices in Puerto Montt, where the Nordic company and its aquaculture subsidiary, Aquatiq, will meet.
BREEZE concept wins EUROPEAN SUSTAINABLE AQUACULTURE COMPETITION
June 2021
The BREEZE initiative which is being developed by a consortium made up of Aqua Pharma Group, Pulcea and the Norwegian University of Science & Technology,
was one of the four projects chosen by EIT Food for inclusion in its 2021 Business Plan for Sustainable Aquaculture.
BREEZE combines Aqua Pharma’s existing hydrogen peroxide treatment with the acoustic based technology pioneered by Pulcea to improve the efficiency of sea lice removal from fish in a gentle treatment. A post-treatment neutralisation leads to decomposition of the hydrogen peroxide into oxygen and water, making the system suitable for use even in environmentally sensitive areas.
Read more about the BREEZE consortium project on our INNOVATION page, or follow us on Social Media to stay tuned.
STRONGER TOGETHER,
A NEW GOVERNANCE STRUCTURE
AQUA PHARMA GROUP
September 2019
Paramove producer, Solvay and Norwegian Food Hygiene expert, Aquatiq have concluded a joint-venture agreement regarding Aqua Pharma Group, reinforcing their long-term collaboration to serve aquaculture customers. With this strong shareholder alliance, Aqua Pharma will be able to put an even stronger focus on research & development, new treatment development, for a diverse range of aquaculture segments.
Aqua Pharma INVESTS in START-UP TECHNOLOGY COMPANY Pulcea
May 2020
The development of an innovative new treatment method to control lice in farmed salmon has moved a step closer with the merging of interests between two experts in the field. Pulcea, which has been developing the use of sound energy to improve the efficiency of existing sea lice treatments, has received investments from Aqua Pharma to accelerate the delivery of its technology, from testing through to commercialisation.